Dual Blockade With AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy--Dafne (GBG-70)

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2774

Related search